Draft:JCO Precision Oncology


JCO Precision Oncology
DisciplineOncology
LanguageEnglish
Edited byJames M. Ford (Stanford Cancer Institute)
Publication details
Publisher
FrequencyMonthly
(2017)
Standard abbreviations
ISO 4JCO Precis. Oncol.
Indexing
ISSN2473-4284
OCLC no.953573973
Links

JCO Precision Oncology (JCO PO) [1] is a peer-reviewed, online-only journal publishing original research, reports, opinions, and reviews that advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer. JCO PO is published by Lippincott, Williams & Wilkins on behalf of the American Society of Clinical Oncology. The editor-in-chief is James M. Ford[2] [3] (Stanford Cancer Institute).

It is indexed in Science Citation Index Expanded (Clarivate)[4] , Scopus (Elsevier), Academic Search Ultimate (EBSCO Industries), Embase (Elsevier), and MEDLINE (United States National Library of Medicine).[5]

See also

edit

References

edit
  1. ^ "JCO Precision Oncology". JCO Precision Oncology.
  2. ^ "Editorial Roster". American Society of Clinical Oncology. Retrieved 2024-08-13.
  3. ^ Ford, James M. (2017-02-23). "Precision Oncology: A New Forum for an Emerging Field". Jco Precision Oncology. 1. American Society of Clinical Oncology: 1–2. doi:10.1200/PO.16.00048. PMID 35172478. Retrieved 2024-08-13.
  4. ^ "JCO Precision Oncology Clairivate". JCO Precision Oncology.
  5. ^ "JCO Precision Oncology". MIAR: Information Matrix for the Analysis of Journals.
edit